Literature DB >> 18657013

Frequency of inappropriate continuation of acid suppressive therapy after discharge in patients who began therapy in the surgical intensive care unit.

Catherine E Murphy1, Alison M Stevens, Nicholas Ferrentino, Bruce A Crookes, James C Hebert, Carter B Freiburg, Jill A Rebuck.   

Abstract

STUDY
OBJECTIVE: To determine the frequency with which patients who begin to receive stress ulcer prophylaxis in the surgical intensive care unit (SICU) are discharged receiving inappropriate acid suppressive therapy (AST).
DESIGN: Prospective, observational evaluation. Setting. Level 1 trauma center and academic tertiary care hospital. PATIENTS: A total of 248 consecutive adult patients admitted to the SICU during a 6-month period who began to receive AST with a proton pump inhibitor or histamine(2)-receptor antagonist.
MEASUREMENTS AND MAIN RESULTS: In most patients (237 [95.6%] of 248), initiation of AST was associated with one or more risk factors for gastrointestinal bleeding. Continuation of AST during hospitalization outside the SICU occurred in 215 patients (86.7%). Sixty patients (24.2%) were discharged from the hospital receiving AST: 52 patients (21.0%) went to skilled nursing facilities or rehabilitation centers, and eight (3.2%) were discharged home. Compared with those whose AST was discontinued in the hospital, patients who continued to receive AST after hospital discharge required extended mechanical ventilation (p=0.001), had twice as many risk factors for gastrointestinal bleeding (p<0.001), were frequently discharged with anticoagulant therapy (p<0.001), exhibited longer hospital and SICU stays (p<0.001), and more frequently demonstrated Glasgow Coma Scale scores of 8 or lower and/or had head injury (p<0.001), hepatic failure (p=0.004), and major trauma (p=0.049). Evaluation of continuation of AST during hospitalization revealed that only 7.4% (16/215) of patients at SICU transfer and 5.0% (3/60) of patients at hospital discharge had a compelling risk factor to continue AST as demonstrated by a coagulopathy at discharge; no patients required mechanical ventilation at hospital discharge.
CONCLUSION: Most patients inappropriately continued to receive stress ulcer prophylaxis during post-SICU hospitalization. Presence of risk factors for stress ulcer-related gastrointestinal bleeding at SICU admission appears to influence continuation of AST after discharge from the hospital. A low percentage (3.2%) of patients was discharged home receiving inappropriate AST, yet overall, few study patients demonstrated a compelling risk factor for continuation of AST.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18657013     DOI: 10.1592/phco.28.8.968

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  12 in total

1.  Overutilization of proton-pump inhibitors: what the clinician needs to know.

Authors:  Joel J Heidelbaugh; Andrea H Kim; Robert Chang; Paul C Walker
Journal:  Therap Adv Gastroenterol       Date:  2012-07       Impact factor: 4.409

2.  Stress ulcer prophylaxis in the intensive care unit.

Authors:  Ladan Mohebbi; Kristen Hesch
Journal:  Proc (Bayl Univ Med Cent)       Date:  2009-10

Review 3.  Stress-related mucosal disease in the critically ill patient.

Authors:  Marc Bardou; Jean-Pierre Quenot; Alan Barkun
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-01-06       Impact factor: 46.802

4.  Impact of a multidisciplinary quality improvement initiative to reduce inappropriate usage of stress ulcer prophylaxis in hospitalized patients.

Authors:  Yeo Jin Choi; Joohyun Sim; Yun Tae Jung; Sooyoung Shin
Journal:  Br J Clin Pharmacol       Date:  2020-01-22       Impact factor: 4.335

5.  Pharmacy student impact on inappropriate prescribing of acid suppressive therapy.

Authors:  Katherine M Carey; Jason E Cross; Matthew A Silva; Mihaela S Stefan; Michael B Rothberg
Journal:  Am J Pharm Educ       Date:  2011-11-10       Impact factor: 2.047

6.  Physicians' opinions of stress ulcer prophylaxis: survey results from a large urban medical center.

Authors:  Charles P Koczka; Laura B Geraldino-Pardilla; Adam J Goodman
Journal:  Dig Dis Sci       Date:  2012-10-12       Impact factor: 3.199

7.  Critical Care Pharmacists and Medication Management in an ICU Recovery Center.

Authors:  Joanna L Stollings; Sarah L Bloom; Li Wang; E Wesley Ely; James C Jackson; Carla M Sevin
Journal:  Ann Pharmacother       Date:  2018-02-18       Impact factor: 3.154

Review 8.  Use of proton pump inhibitors for the provision of stress ulcer prophylaxis: clinical and economic consequences.

Authors:  Jeffrey F Barletta; David A Sclar
Journal:  Pharmacoeconomics       Date:  2014-01       Impact factor: 4.981

Review 9.  Deprescribing versus continuation of chronic proton pump inhibitor use in adults.

Authors:  Taline A Boghossian; Farah Joy Rashid; Wade Thompson; Vivian Welch; Paul Moayyedi; Carlos Rojas-Fernandez; Kevin Pottie; Barbara Farrell
Journal:  Cochrane Database Syst Rev       Date:  2017-03-16

10.  Evaluation of costs accrued through inadvertent continuation of hospital-initiated proton pump inhibitor therapy for stress ulcer prophylaxis beyond hospital discharge: a retrospective chart review.

Authors:  Sooyoung Shin
Journal:  Ther Clin Risk Manag       Date:  2015-05-24       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.